Predicted Risk of Ventricular Arrhythmias in a Genome-First Population With Genetic Risk for Arrhythmogenic Right Ventricular Cardiomyopathy
The predicted 5-year risk of VA in individuals ascertained via population genomic screening for desmosome variants is low (3.9%; 1.6% for fast VA) but may vary by affected gene and ARVC task force criteria burden.
Authors
- Christopher M. Haggerty (ORCID: https://orcid.org/0000-0002-3227-4490)
- Hugh G Calkins (ORCID: https://orcid.org/0000-0002-9262-9433)
- Crystal Tichnell (ORCID: https://orcid.org/0000-0003-3465-294X)
- Brittney Murray (ORCID: https://orcid.org/0000-0001-7870-8584)
- Eric Carruth (ORCID: https://orcid.org/0000-0001-8184-8676)
- Cynthia A. James (ORCID: https://orcid.org/0000-0001-8040-4600)
- K. Young (ORCID: https://orcid.org/0000-0002-9624-3191)
Institutions
- Johns Hopkins University (US)
- Columbia University Irving Medical Center (US)
- Johns Hopkins Bayview Medical Center (US)
- Geisinger Neuroscience Institute (US)
- Genomic Health (United States) (US)
- Geisinger Health System (US)
Publication Details
- Journal
- Circulation Arrhythmia and Electrophysiology
- Published
- 2025-02-24
- DOI
- https://doi.org/10.1161/circep.124.013231
- Citations
- 2
- Primary Topic
- Cardiovascular Effects of Exercise
- Type
- article
- Field-Weighted Citation Impact
- 2.78